Finance

Beta
Lists
VRAX:NASDAQ
Virax Biolabs Group Ltd
$4.08
-35.85%
(-2.28) 1D
$4.08
0.00% (0.00)
After hours
Closed: Jul 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRAX...
Open
$4.92
High
$4.96
Low
$4.01
Mkt. cap
3.25M
Avg. vol.
2.60M
Volume
1.75M
52-wk high
$28.50
52-wk low
$2.50
EPS
-$12.64
Beta
1.35
Shares outstanding
797.00K
No. of employees
26
Open
$4.92
High
$4.96
Low
$4.01
Mkt. cap
3.25M
Avg. vol.
2.60M
Volume
1.75M
52-wk high
$28.50
52-wk low
$2.50
EPS
-$12.64
Beta
1.35
Shares outstanding
797.00K
No. of employees
26
News stories
From sources across the web
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersLondon, England, United Kingdom
SectorHealth care provider
Websiteviraxbiolabs.com
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$1.00
-75.5%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
804.00
804.00
5.41K
5.41K
Cost of goods sold
161.00
161.00
2.21K
2.21K
Cost of revenue
161.00
161.00
2.21K
2.21K
Research and development expenses
689.87K
689.87K
1.18M
1.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
603.51K
603.51K
731.02K
731.02K
Operating expense
1.29M
1.29M
1.91M
1.91M
Total operating expenses
1.29M
1.29M
1.91M
1.91M
Operating income
-1.29M
-1.29M
-1.91M
-1.91M
Other non operating income
-201.00
-201.00
218.00
218.00
EBT including unusual items
-1.31M
-1.31M
-1.66M
-1.66M
EBT excluding unusual items
-1.31M
-1.31M
-1.66M
-1.66M
Income tax expense
-136.80K
-136.80K
-313.32K
-313.32K
Effective tax rate
10.46%
10.46%
18.90%
18.90%
Other operating expenses
-
-
-
-
Net income
-1.17M
-1.17M
-1.34M
-1.34M
Net profit margin
-145,446.02%
-145,446.02%
-24,824.13%
-24,824.13%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-15.50K
-15.50K
-15.39K
-15.39K
Net interest expenses
-15.50K
-15.50K
-15.39K
-15.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.21M
-1.21M
-1.82M
-1.82M
Gain or loss from assets sale
213.00
213.00
15.88K
15.88K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer